• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price

(CAPLIPOINT)

Small Cap

Healthcare Sector

Check the latest share price of Caplin Point Laboratories Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹2018.1▲3.79%

as on 11:55AM, 13 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Caplin Point Laboratories Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,905
    Day's Price Range
    ₹2,033.5

  • 52 Week's Low

    52 Week's High

    ₹1,225
    52-Week Price Range
    ₹2,641
1 Month Return+ 0.98 %
3 Month Return-3.61 %
1 Year Return+ 48.91 %
3 Year Return+ 174.81 %
5 Year Return+ 502.54 %
Previous Close₹1,944.40
Open₹2,018.90
Volume1.37L
Upper Circuit₹2,333.20
Lower Circuit₹1,555.60

Caplin Point Laboratories Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹14,779.71 Cr

Return on Equity (ROE)

22.43

PE Ratio (TTM)

28.67

Return on capital employed (ROCE)

28.84

Industry PE ratio

53.64

Beta (LTM)

0

P/B Ratio

7.2

Dividend Yield

0.38

PEG Ratio

2.81

Quarterly Earnings Growth YOY

16.9

EPS (TTM)

60.75

Sector

Pharmaceuticals

Book Value

276.38

Technical Analysis

Bullish

View Technical Analysis

How to invest in Caplin Point Laboratories Ltd

Investing in Caplin Point Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Caplin Point Laboratories Ltd or CAPLIPOINT on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Caplin Point Laboratories Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Caplin Point Laboratories Ltd with just a few clicks!

Caplin Point Laboratories Ltd Stock's Interest Amongst Investors

-12.83%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Investment in Caplin Point Laboratories Ltd Shares on INDmoney has dropped by -12.83% over the past 30 days, indicating reduced transactional activity.

18%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Search interest for Caplin Point Laboratories Ltd Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Caplin Point Laboratories Ltd Valuation

Track how the P/E of Caplin Point Laboratories Ltd has moved over time to understand valuation trends.

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (28.67x)

May 12, 2025

Industry (53.64x)

May 12, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 28.67x

Analysts Recommendation on Caplin Point Laboratories Ltd

Get updated buy, sell, and hold recommendations by analysts on Caplin Point Laboratories Ltd.

based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2472

Source: S&P Global Market Intelligence

Analysts Forecast on Caplin Point Laboratories Ltd

Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd price forecast by 3 analysts

Upside of27.13%

High

₹2516

Target

₹2472.00

Low

₹2400

Caplin Point Laboratories Ltd target price ₹2472, a slight upside of 27.13% compared to current price of ₹2018.1. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Financials

Get the annual and quarterly financial summary of Caplin Point Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue

(in ₹ Cr)

436 (0%)453 (4%)459 (1%)483 (5%)493 (2%)
Net Income

(in ₹ Cr)

120 (0%)121 (1%)125 (3%)131 (5%)140 (7%)
Net Profit Margin27.51% (0%)26.75% (3%)27.22% (2%)27.08% (1%)28.41% (5%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

861 (0%)1054 (22%)1303 (24%)1522 (17%)
Total Liabilities

(in ₹ Cr)

102 (0%)124 (21%)163 (32%)132 (19%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

87 (0%)295 (239%)231 (22%)157 (32%)111 (29%)

Caplin Point Laboratories Ltd Index Inclusions

BSE Healthcare

₹42,109.65

1.23 (▲510.36%)

S&P BSE 400 MidSmallCap

₹11,381.68

0.56 (▲63.39%)

S&P BSE 250 SmallCap

₹6,344.13

0.79 (▲49.93%)

Nifty Smallcap 250

₹15,811.05

0.81 (▲126.85%)

BSE 500

₹35,307.19

-0.3 (▲-105.21%)

Nifty 500

₹22,453.50

-0.26 (▲-57.9%)

Nifty MidSmallcap 400

₹18,767.65

0.67 (▲124.65%)

BSE Small-Cap

₹49,197.68

1.03 (▲503.93%)

Caplin Point Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 18.57% since last year same period to ₹138.96Cr in the Q3 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 6.24% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2024

    In the quarter ending June 2024, Caplin Point Laboratories Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.39%.

    Read More about Dividends

Caplin Point Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Caplin Point Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
5.7%
0.00
Mutual Funds
1.74%
0.00
Retail Investors
21.7%
0.00
Others
0.29%
0.00

Caplin Point Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
BUY14,779.71100.51%0.504611,694
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY27,067.89109.92%0.523001,051
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY14,004.8627.28%0.57726,702
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA4,823.362.39%0.79-38875
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY13,733.8540.08%0.682181,296
See all

Caplin Point Laboratories Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Caplin Point Laboratories Ltd.

  • Caplin Steriles Secures USFDA Approval for Injectable - 23 Apr, 2025

    Caplin Point Laboratories' subsidiary, Caplin Steriles, has received USFDA approval for Phytonadione Injectable Emulsion, expanding its presence in the U.S. generics market. The product addresses Vitamin K deficiency and has a market size of approximately $18.5 million.

  • Caplin Point Acquires Neoethicals, Reports Strong Growth - 03 Apr, 2025

    Caplin Point Laboratories' subsidiary acquires Neoethicals Chile SpA, boosting its presence in South America. The company also reports a 13% revenue increase in Q3 FY25.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.86% to 5.70% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CAPLIPOINT stock has moved up by 48.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 13 quarters, 74.95 Cr → 138.96 Cr (in ₹), with an average increase of 5.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 18 quarters, 269.88 Cr → 524.32 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.9% return, outperforming this stock by 3.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.86% to 1.74% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 22.47% to 21.70% in Mar 2025 quarter

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹492.96Cr as on December 2024 (Q4 24)
Net Profit: ₹140.07Cr as on December 2024 (Q4 24)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

Indian Mutual Funds that own Caplin Point Laboratories Ltd

Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.

FAQs

What is Caplin Point Laboratories Ltd price today?

Caplin Point Laboratories Ltd share price today stands at ₹2018.1, Open: ₹2018.9, Previous Close: ₹1944.4, High: ₹2033.5, Low: ₹1905, 52 Week High: ₹2641, 52 Week Low: ₹1225.

How to Buy Caplin Point Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Caplin Point Laboratories Ltd shares

What are today's traded volumes of Caplin Point Laboratories Ltd?

Today's traded volume of Caplin Point Laboratories Ltd(CAPLIPOINT) is 1.37L.

What is today's market capitalisation of Caplin Point Laboratories Ltd?

Today's market capitalisation of Caplin Point Laboratories Ltd(CAPLIPOINT) is ₹14,779.71 Cr.

What is the 52 Week High and Low Range of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd (CAPLIPOINT)
Price
52 Week High
₹2641
52 Week Low
₹1225

How much percentage Caplin Point Laboratories Ltd is down from its 52 Week High?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹2018.1. It is down -23.59% from its 52 Week High price of ₹2641

How much percentage Caplin Point Laboratories Ltd is up from its 52 Week low?

Caplin Point Laboratories Ltd (CAPLIPOINT) share price is ₹2018.1. It is up 64.74% from its 52 Week Low price of ₹1225